4.3 Article

FAM83D promotes cell proliferation and motility by downregulating tumor suppressor gene FBXW7

Journal

ONCOTARGET
Volume 4, Issue 12, Pages 2476-2486

Publisher

IMPACT JOURNALS LLC
DOI: 10.18632/oncotarget.1581

Keywords

FAM83D; FBXW7; breast cancer; epithelial-mesenchymal transition; invasion

Funding

  1. National Natural Science Foundation of China [81172528, 31271461]
  2. Ministry of Education of China [20110131110035]
  3. Natural Science Foundation of Shandong Province [ZR2011HM034]
  4. National Institutes of Health, National Cancer Institute [R01 CA116481]
  5. Low Dose Scientific Focus Area, Office of Biological & Environmental Research, US Department of Energy [DE-AC02-05CH11231]

Ask authors/readers for more resources

Amplification of chromosome 20q is frequently found in various types of human cancers, including breast cancer. The list of candidate oncogenes in 20q has expanded over the past decade. Here, we investigate whether FAM83D (family with sequence similarity 83, member D) on chromosome 20q plays any role in breast cancer development. The expression level of FAM83D is significantly elevated in breast cancer cell lines and primary human breast cancers. High expression levels of FAM83D are significantly associated with poor clinical outcome and distant metastasis in breast cancer patients. We show that ectopic expression of FAM83D in human mammary epithelial cells promotes cell proliferation, migration and invasion along with epithelial-mesenchymal transition (EMT). Ablation of FAM83D in breast cancer cells induces apoptosis and consequently inhibits cell proliferation and colony formation. Mechanistic studies reveal that overexpression of FAM83D downregulates FBXW7 expression levels through a physical interaction, which results in elevated protein levels of oncogenic substrates downstream to FBXW7, such as mTOR, whose inhibition by rapamycin can suppress FAM83D-induced cell migration and invasion. The results demonstrate that FAM83D has prognostic value for breast cancer patients and is a novel oncogene in breast cancer development that at least in part acts through mTOR hyper-activation by inhibiting FBXW7.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

Identification of a novel cancer microbiome signature for predicting prognosis of human breast cancer patients

A. W. Mao, H. Barck, J. Young, A. Paley, J-H Mao, H. Chang

Summary: The study identified a 15-microbe prognostic signature for breast cancer patients by analyzing TCGA BC microbiome data, which showed good predictive efficacy in patient survival and progression-free survival. The microbial abundance prognostic scoring model was found to be an independent prognostic factor for overall survival and progression-free survival, outperforming previously published gene signatures.

CLINICAL & TRANSLATIONAL ONCOLOGY (2022)

Article Oncology

Validation of Anticorrelated TGFβ Signaling and Alternative End-Joining DNA Repair Signatures that Predict Response to Genotoxic Cancer Therapy

Ines Guix, Qi Liu, Miquel Angel Pujana, Patrick Ha, Josep Piulats, Isabel Linares, Ferran Guedea, Jian-Hua Mao, Ann Lazar, Jocelyn Chapman, Sue S. Yom, Alan Ashworth, Mary Helen Barcellos-Hoff

Summary: This study confirms the anticorrelation between TGF beta signaling and alt-EJ gene expression signatures, as well as their predictive value for response to genotoxic therapy. The findings validate the role of TGF beta as a key mediator of DNA repair and demonstrate the feasibility of using gene expression to assess TGF beta signaling and DNA repair.

CLINICAL CANCER RESEARCH (2022)

Article Multidisciplinary Sciences

A new platform for ultra-high dose rate radiobiological research using the BELLA PW laser proton beamline

Jianhui Bin, Lieselotte Obst-Huebl, Jian-Hua Mao, Kei Nakamura, Laura D. Geulig, Hang Chang, Qing Ji, Li He, Jared De Chant, Zachary Kober, Anthony J. Gonsalves, Stepan Bulanov, Susan E. Celniker, Carl B. Schroeder, Cameron G. R. Geddes, Eric Esarey, Blake A. Simmons, Thomas Schenkel, Eleanor A. Blakely, Sven Steinke, Antoine M. Snijders

Summary: Radiotherapy is the standard treatment for over 50% of cancer patients, and the use of FLASH-RT may provide additional benefits. Researchers have developed an experimental platform that delivers ultra-high dose rates of proton pulses to biological samples. Preliminary findings show that normal cells have higher survival rates compared to tumor cells at high dose rates.

SCIENTIFIC REPORTS (2022)

Review Oncology

Pathophysiological Integration of Metabolic Reprogramming in Breast Cancer

Roberto Corchado-Cobos, Natalia Garcia-Sancha, Marina Mendiburu-Elicabe, Aurora Gomez-Vecino, Alejandro Jimenez-Navas, Manuel Jesus Perez-Baena, Marina Holgado-Madruga, Jian-Hua Mao, Javier Canueto, Sonia Castillo-Lluva, Jesus Perez-Losada

Summary: Metabolic changes in tumor cells and their interactions with stromal cells play a crucial role in tumor growth and progression. Understanding these metabolic changes can help identify new treatment strategies. Breast cancer serves as a useful example to illustrate the metabolic alterations in cancer.

CANCERS (2022)

Article Oncology

From Mouse to Human: Cellular Morphometric Subtype Learned From Mouse Mammary Tumors Provides Prognostic Value in Human Breast Cancer

Hang Chang, Xu Yang, Jade Moore, Xiao-Ping Liu, Kuang-Yu Jen, Antoine M. Snijders, Lin Ma, William Chou, Roberto Corchado-Cobos, Natalia Garcia-Sancha, Marina Mendiburu-Elicabe, Jesus Perez-Losada, Mary Helen Barcellos-Hoff, Jian-Hua Mao

Summary: Mouse models of cancer play an important role in investigating cancer biology. This study developed a machine learning approach to identify cellular morphometric biomarkers from digital images of mammary tumors, and demonstrated their significance in predicting survival and metastasis. The findings suggest that this approach can provide unbiased biological stratification to guide patient care.

FRONTIERS IN ONCOLOGY (2022)

Article Immunology

Prospective Study Reveals Host Microbial Determinants of Clinical Response to Fecal Microbiota Transplant Therapy in Type 2 Diabetes Patients

Dafa Ding, Huijuan Yong, Na You, Wei Lu, Xu Yang, Xiaolong Ye, Yayun Wang, Tingting Cai, Xiaoling Zheng, Hui Chen, Bota Cui, Faming Zhang, Xingyin Liu, Jian-Hua Mao, Yibing Lu, Hang Chang

Summary: This study found that fecal microbiota transplantation (FMT) therapy can improve symptoms and metabolic parameters in patients with type 2 diabetes mellitus (T2DM). Out of 17 patients, 11 showed significant improvement. Additionally, the presence of certain microbial species can predict the clinical response to FMT treatment.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2022)

Article Cell Biology

A Novel DNA Repair Gene Signature for Immune Checkpoint Inhibitor-Based Therapy in Gastric Cancer

Binbin Yuan, Chengfei Jiang, Lingyan Chen, Lihui Wen, Jinlong Cui, Min Chen, Shu Zhang, Lin Zhou, Yimeng Cai, Jian-Hua Mao, Xiaoping Zou, Bo Hang, Pin Wang

Summary: Through evaluating the DNA repair gene signature in gastric cancer patients, this study found that patients with high scores had better therapeutic outcomes with immune checkpoint blockade therapy. These high DRGS score patients exhibited higher levels of anti-tumor lymphocyte infiltration, tumor mutation burden, PD-L1 expression, and longer overall survival.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)

Article Oncology

Clinical significance and molecular annotation of cellular morphometric subtypes in lower-grade gliomas discovered by machine learning

Xiao-Ping Liu, Xiaoqing Jin, Saman Seyed Ahmadian, Xu Yang, Su-Fang Tian, Yu-Xiang Cai, Kuldeep Chawla, Antoine M. Snijders, Yankai Xia, Paul J. van Diest, William A. Weiss, Jian-Hua Mao, Zhi-Qiang Li, Hannes Vogel, Hang Chang

Summary: By developing and validating cellular morphometric subtypes (CMS), personalized diagnosis and therapy for LGG patients can be achieved. These subtypes can predict patient prognosis and treatment response based on molecular alterations and immune microenvironment, and also have translational impact on glioblastoma.

NEURO-ONCOLOGY (2023)

Article Veterinary Sciences

Effect of Husbandry Practices on the Fecal Microbiota of C57BL/6J Breeding Colonies Housed in 2 Different Barrier Facilities in the Same Institution

Libette J. Roman, Antoine M. Snijders, Hang Chang, Jian-Hua Mao, Kristina J. A. Jones, Gregory W. Lawson

Summary: This study examines the effect of different barrier practices on the fecal microbiome of breeding C57Bl/6J mice. The results show that differences in barrier husbandry practices can affect fecal microbiome divergence in both the parental and filial generations of different breeding colonies.

JOURNAL OF THE AMERICAN ASSOCIATION FOR LABORATORY ANIMAL SCIENCE (2023)

Article Environmental Sciences

Thirdhand tobacco smoke exposure increases the genetic background-dependent risk of pan-tumor development in Collaborative Cross mice

Hui Yang, Xinzhi Wang, Pin Wang, Li He, Suzyann F. Schick, Peyton Jacob, Neal Benowitz, Lara A. Gundel, Chi Zhu, Yankai Xia, Jamie L. Inman, Hang Chang, Antoine M. Snijders, Jian-Hua Mao, Bo Hang

Summary: Increasing evidence suggests that thirdhand smoke (THS) exposure has adverse health effects and may increase cancer risk. This study used the Collaborative Cross (CC) mouse population-based model system to assess the effects of THS exposure on cancer risk and found an increased incidence and burden of tumors in THS-treated mice. Lung and liver tissues were particularly susceptible to tumorigenesis after THS exposure. The study also highlighted the importance of host genetic background in individual susceptibility to THS-induced tumorigenesis and emphasized the need to consider genetic factors when determining cancer risk in humans exposed to THS.

ENVIRONMENT INTERNATIONAL (2023)

Article Substance Abuse

Policy-relevant differences between secondhand and thirdhand smoke: strengthening protections from involuntary exposure to tobacco smoke pollutants

Georg E. Matt, Lydia Greiner, Rachael A. Record, Heather Wipfli, Jamie Long, Nathan G. Dodder, Eunha Hoh, Nicolas Lopez Galvez, Thomas E. Novotny, Penelope J. E. Quintana, Hugo Destaillats, Xiaochen Tang, Antoine M. Snijders, Jian-Hua Mao, Bo Hang, Suzaynn Schick, Peyton Jacob, Prue Talbot, E. Melinda Mahabee-Gittens, Ashley L. Merianos, Thomas F. Northrup, Lara Gundel, Neal L. Benowitz

Summary: Since the 1970s, policies prohibiting smoking indoors have saved numerous lives and reduced healthcare expenditure. However, these policies do not fully protect the public from the long-lasting toxic residues of tobacco smoke, known as thirdhand smoke. This article discusses the differences between secondhand and thirdhand smoke exposure and proposes four policy considerations to better protect the public and remediate thirdhand smoke.

TOBACCO CONTROL (2023)

Article Endocrinology & Metabolism

Fecal microbiota transplantation ameliorates type 2 diabetes via metabolic remodeling of the gut microbiota in db/db mice

Lijuan Chen, Lin Guo, Susu Feng, Congcong Wang, Zhicheng Cui, Sijing Wang, Qingmiao Lu, Hang Chang, Bo Hang, Antoine M. Snijders, Jian-Hua Mao, Yibing Lu, Dafa Ding

Summary: This study confirms the effectiveness of FMT in treating patients with T2DM and demonstrates its positive impact on gut microbiome, serum metabolites, intestinal epithelial barrier, inflammation, and circulating immune cells.

BMJ OPEN DIABETES RESEARCH & CARE (2023)

Article Cell Biology

Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk

Aurora Gomez-Vecino, Roberto Corchado-Cobos, Adrian Blanco-Gomez, Natalia Garcia-Sancha, Sonia Castillo-Lluva, Ana Martin-Garcia, Marina Mendiburu-Elicabe, Carlos Prieto, Sara Ruiz-Pinto, Guillermo Pita, Alejandro Velasco-Ruiz, Carmen Patino-Alonso, Purificacion Galindo-Villardon, Maria Linarejos Vera-Pedrosa, Jose Jalife, Jian-Hua Mao, Guillermo Macias de Plasencia, Andres Castellanos-Martin, Maria del Mar Saez-Freire, Susana Fraile-Martin, Telmo Rodrigues-Teixeira, Carmen Garcia-Macias, Julie Milena Galvis-Jimenez, Asuncion Garcia-Sanchez, Maria Isidoro-Garcia, Manuel Fuentes, Maria Begona Garcia-Cenador, Francisco Javier Garcia-Criado, Juan Luis Garcia-Hernandez, Maria Angeles Hernandez-Garcia, Juan Jesus Cruz-Hernandez, Cesar Augusto Rodriguez-Sanchez, Alejandro Martin Garcia-Sancho, Estefania Perez-Lopez, Antonio Perez-Martinez, Federico Gutierrez-Larraya, Antonio J. Carton, Jose Angel Garcia-Saenz, Ana Patino-Garcia, Miguel Martin, Teresa Alonso-Gordoa, Christof Vulsteke, Lieselot Croes, Sigrid Hatse, Thomas Van Brussel, Diether Lambrechts, Hans Wildiers, Hang Chang, Marina Holgado-Madruga, Anna Gonzalez-Neira, Pedro L. Sanchez, Jesu Perez Losada

Summary: Cardiotoxicity due to anthracyclines (CDA) affects cancer patients, and identifying individuals at risk is challenging. In this study, the authors investigated intermediate molecular phenotypes (IMPs) associated with myocardial damage to determine CDA susceptibility. By analyzing a mouse cohort treated with doxorubicin and docetaxel, they identified genetic markers linked to IMPs and CDA. These markers were also found to be associated with CDA in cancer patients, highlighting their potential as predictive factors. Additionally, genetic risk scores were generated using machine-learning regression to personalize patient management.

CELLS (2023)

Article Oncology

Pan-cancer evaluation of clinical value of mitotic network activity index (MNAI) and its predictive value for immunotherapy

Xuanyu Mao, Yimeng Cai, Sarah Long, Jesus Perez-Losada, Jian-Hua Mao, Hang Chang

Summary: Increased mitotic activity is associated with the genesis and aggressiveness of many cancers. The mitotic network activity index (MNAI) constructed based on a 54-gene mitotic apparatus network has been evaluated as a potential prognostic biomarker in a pan-cancer study. The study confirmed the significant association of MNAI with overall survival, progression-free survival, and other prognostic endpoints in multiple cancer types, and also revealed its association with genetic instability and treatment response.

FRONTIERS IN ONCOLOGY (2023)

Article Microbiology

Complete genome sequence of the Microbacterium sp. strain BDGP8

Kenneth H. H. Wan, Soo Park, Benjamin W. W. Booth, Ella C. C. Brydon, Joanne Eichenberger, Jamie L. L. Inman, Jian-Hua Mao, Antoine M. M. Snijders, Susan E. E. Celniker

Summary: Microbacterium sp. BDGP8 is a facultative anaerobic gram-positive bacterium belonging to the family Microbacteriaceae. Its complete genome consists of a single circular chromosome of 3,293,567 bp with a G + C content of 69.84% and two plasmids of 49,365 bp and 32,884 bp.

MICROBIOLOGY RESOURCE ANNOUNCEMENTS (2023)

No Data Available